Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis
BackgroundBehavioral interventions can meaningfully improve cardiometabolic conditions. Digital therapeutics (DTxs) delivering these interventions may provide benefits comparable to pharmacologic therapies, displacing medications for some patients. ObjectiveOur objective was to estimate the economic...
Saved in:
Main Authors: | Nordyke, Robert J (Author), Appelbaum, Kevin (Author), Berman, Mark A (Author) |
---|---|
Format: | Book |
Published: |
JMIR Publications,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimation of the Various Urinary Biomarkers among the Non-Hypertensive Type 2 Diabetic Patients with Nephropathy
by: Sudarshan Chakraborty, et al.
Published: (2024) -
Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: An initiative for the digital transformation of health
by: Thamir M. Alshammari, et al.
Published: (2023) -
The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks
by: Kevin Yan, et al.
Published: (2021) -
Incretins and SGLT-2i Therapy of Type 2 Diabetes - Real Life Study of Their Therapeutic and Economic Effects
by: Zornitsa Mitkova, et al.
Published: (2019) -
Evidence-based approach for managing hypertension in type 2 diabetes
by: Gerti Tashko, et al.
Published: (2010)